What is the best deal structure for NEU?
A higher upfront payment will be paired with a lower revenue/royalty share going forward.
If we believe Trofinetide will be successful then surely we want to retain as large a portion of the future revenue as possible?
Personally, I will be disappointed if it is a large upfront payment at the expense of a larger share of future revenues. I guess it's a case of waiting to see... I have confidence that Dr. Treagus will do what is best for the long-term value of NEU
- Forums
- ASX - By Stock
- NASDAQ vs Aussie biotechs and licensing deals
What is the best deal structure for NEU? A higher upfront...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.51 |
Change
-0.520(3.05%) |
Mkt cap ! $2.106B |
Open | High | Low | Value | Volume |
$16.94 | $17.02 | $16.39 | $6.880M | 411.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 461 | $16.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.51 | 99 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 613 | 16.490 |
8 | 1124 | 16.480 |
8 | 949 | 16.470 |
5 | 743 | 16.460 |
5 | 734 | 16.450 |
Price($) | Vol. | No. |
---|---|---|
16.500 | 231 | 1 |
16.510 | 853 | 18 |
16.520 | 890 | 8 |
16.530 | 747 | 7 |
16.540 | 438 | 4 |
Last trade - 14.40pm 13/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online